US-based pharmaceutical company CEL-SCI has entered into an exclusive licensing agreement with Byron Biopharma under which CEL-SCI has granted Byron an exclusive license to market and distribute the
The company’s corporate controller, Len Ross, will become the principal financial and accounting officer. Paul Ashton, president and CEO of pSivida, said: “The company and the board of
Maureen Loftus, president of IBT, said: “IBT Laboratories was one of the first laboratories to develop a commercial pneumococcal assay to measure the concentration of antibodies produced in
Related to this, Biotie-Lundbeck licensing agreement terms have been amended. Under the terms of the amended agreement, Biotie is now eligible for up to E84 million in upfront
GlobalStem will provide full characterization of the cells including sterility and mycoplasma detection testing, karyotyping and assaying for critical markers. CHDI has generated various Huntington’s disease mouse embryonic
Under the terms of the non-exclusive partnership, Home Service will deliver prescription drugs on behalf of Healthscreen to patients electing for a home delivery option during the diabetes
Dr Cohen has spent more than two decades in the healthcare field. Before joining governor Mr Paterson as his chief policy advisor, Dr Cohen served as managing director
Under the new contract, members of Aetna’s Medicare Advantage health maintenance organization and preferred provider organization plans, will be able to receive covered benefits, at in-network rates, from
The product, as yet unnamed, has been FDA cleared for both over-the-counter and prescription-only marketing and distribution. The new stabilized antimicrobial wound gel contains antimicrobial silver in an
Assay Design’s senior management will remain actively involved with Enzo Life Sciences. With this latest acquisition, Enzo Life Sciences now has US operations in New York, Pennsylvania, Michigan
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.